Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Opus Genetics (IRD) Assets Average (2019 - 2026)

Opus Genetics has reported Assets Average over the past 12 years, most recently at $58.5 million for Q1 2026.

  • Quarterly Assets Average rose 37.64% to $58.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $58.5 million through Mar 2026, up 37.64% year-over-year, with the annual reading at $43.6 million for FY2025, 4.08% down from the prior year.
  • Assets Average was $58.5 million for Q1 2026 at Opus Genetics, up from $43.2 million in the prior quarter.
  • Over five years, Assets Average peaked at $58.5 million in Q1 2026 and troughed at $16.2 million in Q3 2022.
  • The 5-year median for Assets Average is $43.2 million (2025), against an average of $40.7 million.
  • Year-over-year, Assets Average plummeted 33.0% in 2022 and then soared 200.79% in 2023.
  • A 5-year view of Assets Average shows it stood at $31.8 million in 2022, then skyrocketed by 70.14% to $54.1 million in 2023, then decreased by 28.56% to $38.6 million in 2024, then increased by 11.8% to $43.2 million in 2025, then skyrocketed by 35.51% to $58.5 million in 2026.
  • Per Business Quant, the three most recent readings for IRD's Assets Average are $58.5 million (Q1 2026), $43.2 million (Q4 2025), and $37.4 million (Q3 2025).